Arcus Biosciences, Inc.
RCUSDrugs in Pipeline
7
Phase 3 Programs
5
Upcoming Catalysts
4
Next Catalyst
Dec 2026
Market Overview
Stock performance and key metrics
4 upcoming, 1 past
How RCUS's past catalysts played out
Zimberelimab
Non Small Cell Lung Cancer
Nab-paclitaxel
Metastatic Pancreatic Ductal Adenocarcinoma
Casdatifan
Metastatic Clear Cell Renal Cell Carcinoma
Domvanalimab
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Quemliclustat
Gastrointestinal Tract Malignancies
Etrumadenant
Prostatic Neoplasms, Castration-Resistant
AB680
Metastatic Colorectal Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Zimberelimab | Phase 3 | Non Small Cell Lung Cancer | - | - |
Nab-paclitaxel | Phase 3 | Metastatic Pancreatic Ductal Adenocarcinoma | - | - |
Casdatifan | Phase 3 | Metastatic Clear Cell Renal Cell Carcinoma | - | - |
Domvanalimab | Phase 3 | Advanced Upper Gastrointestinal Tract Adenocarcinoma | - | - |
Quemliclustat | Phase 3 | Gastrointestinal Tract Malignancies | - | - |
Etrumadenant | Phase 2 | Prostatic Neoplasms, Castration-Resistant | - | - |
AB680 | Phase 2 | Metastatic Colorectal Cancer | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Arcus Biosciences, Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in Arcus Biosciences, Inc.'s (RCUS) pipeline across Phase 3, Phase 2. Its lead program is Zimberelimab (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Arcus Biosciences, Inc.'s next FDA catalyst?→
Arcus Biosciences, Inc.'s (RCUS) next tracked catalyst is a Trial Start expected December 31, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RCUS biotech catalysts?→
Add RCUS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Arcus Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.